ProMIS Neurosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ProMIS Neurosciences generated cash of -$14,367,545, which is more than the previous year. Cash used in financing activities reached the amount of $23,516,627 last year. Net change in cash is therefore $8,736,632.
Cash Flow
| 2014 | -1.62M | 0 | 1.71M |
|---|---|---|---|
| 2015 | -1.13M | -29.54K | 2.49M |
| 2016 | -1.89M | -152 | 1.75M |
| 2017 | -4.53M | -163 | 5.30M |
| 2018 | -6.34M | -151 | 6.86M |
| 2019 | -4.66M | -159 | 4.10M |
| 2020 | -3.41M | -87.73K | 3.00M |
| 2021 | -9.28M | 94.33K | 25.20M |
| 2022 | -17.03M | -1.98K | 6.49M |
| 2023 | -14.36M | -1.78K | 23.51M |
PMN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.95M | 16.94M | 807.02K | 1.30M | 1.82M | 1.24M | 566.23K | 671.98K | 18.02K | 32.79K |
Operating activities | ||||||||||
Net income | -17.50M | -18.06M | -9.24M | -4.44M | -5.66M | -7.46M | -4.78M | -2.57M | -1.52M | -2.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 21.15M | 11.21K | 45.68K | 12.33K | 6.55K | 4.89K | 5.30K | 4.96K | 5.50K | 14.77K |
Stock-based compensation expense | 271.54M | 487.63K | 515.62K | 205.35K | 495.60K | 0 | 552.11K | 425.25K | 401.56K | 520.49K |
| Deferred income tax benefit | 271.54M | 487.63K | 515.62K | 205.35K | 495.60K | 0 | 552.11K | 425.25K | 401.56K | 520.49K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 27.16K | -19.55K | 0 | 0 | 0 | 0 | -230.16K |
Inventories | 0 | 0 | 0 | -30.28K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 2.67M | -31.55K | 72.78K | 572.70K | 331.43K | -303.52K | 0 | 0 | 0 |
Cash generated by operating activities | -14.36M | -17.03M | -9.28M | -3.41M | -4.66M | -6.34M | -4.53M | -1.89M | -1.13M | -1.62M |
Investing activities | ||||||||||
Purchases Of Investments | -32.35M | -31.00K | -33.00K | -32.96K | -32.01K | -30.55K | -32.93K | -30.65K | -29.54K | 0 |
Investments In Property Plant And Equipment | 0 | -1.98K | -6.02K | -85.21K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 2.35K | -2.35K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.78K | -1.98K | 94.33K | -87.73K | -159 | -151 | -163 | -152 | -29.54K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 4.97M | 20.01M | 0 | 4.03M | 5.54M | 5.34M | 1.74M | 1.70M | 1.71M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -1.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -6.91M | 0 | 0 | 0 | -89.32K | 0 | 0 | 0 |
Cash used in financing activities | 23.51M | 6.49M | 25.20M | 3.00M | 4.10M | 6.86M | 5.30M | 1.75M | 2.49M | 1.71M |
Net Change In Cash | 8.73M | -11.06M | 16.01M | -496.20K | -557.26K | 513.86K | 777.5K | -142.22K | 632.85K | 90.98K |
Cash at end of period | 16.69M | 5.87M | 16.81M | 806.93K | 1.27M | 1.75M | 1.34M | 529.75K | 650.87K | 123.78K |
| Data source | Data source |